Another study conducted by the same group of scientists revealed that MAG treatment of 5637 bladder cancer cells inhibits expression of MMP-9 induced by Tumor necrosis factor–alpha (TNF-α) by decreasing the binding affinity of the transcription factor NF-κB to the MMP-9 promoter [103]. The gene discussed is MMP9; the disease is urinary bladder carcinoma.